Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

Preview: Centralnic unlikely to spring any surprises

Internet domain name firm set to stay with consensus numbers

CentralNic Group PLC (LON:CNIC) is likely to stick to its guns when the internet domain name firm reports half-year results on Wednesday.

The company, which acts as a wholesaler and technical partner to companies selling new internet domains, is unlikely to make significant changes to consensus numbers, according to broker Peel Hunt.

Its May update indicated that pre-tax underlying earnings rose 89% to £3.3m and, following the acquisition of Instra Group at the start of 2016, are forecast to increase 80% in the current year.

Rises in earnings per share are lower this year owing to the normalisation of its tax rate and shares issued in the recent fundraising, the broker said.

However, earnings growth should accelerate in 2017 and the free cash flow yield provides a clear underpinning this year.

“We believe the shares will re-rate as the company gains scale and its reliance on aftermarket sales decreases,” Peel Hunt analyst Paraag Amin said.

Meanwhile, Puretech Health PLC (LON:PRTC) is tipped to update on funding for its operating company Akili Interactive Labs at its half-year results.

Numis Securities said: “We expect a summary of progress to include recent funding rounds for Akili and Vedanta, both of which involved significant participation from external investors, as well as a preview of upcoming newsflow.”

The broker expects Puretech to report full-year revenue of US$400,000 and an increased operating loss of US$87.9mln as spending, mainly into research and development in its growth stage companies, steps up.

Analyst Stefan Hamill added: “It has been a busy c.14 months as a public company with the June 2015 IPO proceeds of US$196mln leaving the business well-funded in the medium term.”

Companies also reporting include:

Finals: Barratt Developments, Hargreaves Lansdown, Joules Group, McBride.

Interims: Ashtead, Sanne Group, Servelec, Zegona Communications.

AGMs: Carpetright, CMC Markets, Poundland, Sports Direct.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK